Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy
Stat
Mon, 08/28/17 - 10:04 am
Gilead Sciences
Kite Pharma
CAR-T
M&A
axi-cel
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
Stat
Wed, 08/23/17 - 11:41 am
CAR-T
Novartis
drug pricing
CTL019
leukemia
Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing
Fierce Pharma
Tue, 08/22/17 - 12:05 am
Novartis
Pharma CEOs
CAR-T
Joe Jimenez
drug pricing
Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study
Endpoints
Sat, 08/19/17 - 10:29 am
Medvir
hepatitis C
China
Ascletis
Cellectis
UCART123
CAR-T
With CAR-T marketing looming, early study highlights potential of TCR engineering
Endpoints
Fri, 08/18/17 - 12:06 pm
CAR-T
Kite Pharma
Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race
Endpoints
Mon, 07/31/17 - 09:57 am
Kite Pharma
CAR-T
Europe
Novartis
axicabtagene ciloleucel
CAR-T Cell Therapy Is Here To Stay
Forbes
Wed, 07/19/17 - 09:40 am
CAR-T
cell therapy
Novartis
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Fri, 07/14/17 - 08:07 am
Novartis
CAR-T
CTL019
Kite Pharma
Bluebird Bio
Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
Fierce Pharma
Wed, 07/12/17 - 04:29 pm
Novartis
CAR-T
FDA
advisory panels
CTL019
D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T
Endpoints
Wed, 07/12/17 - 11:00 am
Novartis
FDA
CAR-T
CTL019
FDA panel to focus on safety of Novartis gene therapy drug
Yahoo/Reuters
Mon, 07/10/17 - 09:32 am
FDA
advisory panels
Novartis
gene therapy
CAR-T
acute lymphoblastic leukemia
Novartis turns to Oxford BioMedica for a major CAR-T supply deal
Endpoints
Thu, 07/6/17 - 02:35 pm
Novartis
Oxford BioMedica
CAR-T
CTL019
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Investors Business Daily
Sun, 07/2/17 - 10:07 am
Celgene
Bluebird Bio
Kite Pharma
Juno Therapeutics
CAR-T
immuno-oncology
bb2121
3 Top-Performing Biotech Stocks This Week
Motley Fool
Fri, 06/16/17 - 09:51 am
biotech
Kite Pharma
KTE-C19
Bluebird Bio
CAR-T
Lexicon Pharmaceuticals
With Kite’s PDUFA date looming, federal court tosses Juno’s CAR-T patent challenge — for now
Endpoints
Wed, 06/14/17 - 11:43 am
Kite Pharma
PDUFA
CAR-T
patents
Juno Therapeutics
KTE-C19
Kite Pharma: How High Will It Fly?
Seeking Alpha
Tue, 06/13/17 - 10:33 am
Kite Pharma
CAR-T
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Bloomberg
Thu, 06/8/17 - 10:24 pm
Novartis
drug pricing
CTL019
cancer
CAR-T
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
ASCO17: Juno marks progress with second-gen CAR-T
BioPharma Dive
Tue, 06/6/17 - 12:16 pm
ASCO 2017
Juno Therapeutics
CAR-T
JCAR017
non-Hodgkin's lymphoma
JCAR015
July 12 FDA panel review looms as a watershed moment in Novartis’ campaign to win an historic new drug OK
Endpoints
Tue, 06/6/17 - 12:13 pm
Novartis
FDA
CAR-T
advisory panels
CTL019
pediatric B-cell acute lymphoblastic leukemia
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »